Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?

A J A Keen; E Duncan; A McKillop-Smith; N D Evans; A E Gold

doi:10.1111/j.1464-5491.2011.03479.x

Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?

A J A Keen, E Duncan, A McKillop-Smith, N D Evans, A E Gold

Applied Health Sciences

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

Abstract

Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P

Original language	English
Pages (from-to)	670-676
Number of pages	6
Journal	Diabetic Medicine
Volume	29
Issue number	5
Early online date	16 Apr 2012
DOIs	https://doi.org/10.1111/j.1464-5491.2011.03479.x
Publication status	Published - May 2012

Keywords

education
patient education
Type 1 diabetes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1464-5491.2011.03479.x

Cite this

@article{075f4166fffb4f05b01e21a13e35a3f1,

title = "Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?",

abstract = "Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P ",

keywords = "education, patient education, Type 1 diabetes",

author = "Keen, {A J A} and E Duncan and A McKillop-Smith and Evans, {N D} and Gold, {A E}",

note = "Journal compilation {\textcopyright} 2011 Diabetes UK.",

year = "2012",

month = may,

doi = "10.1111/j.1464-5491.2011.03479.x",

language = "English",

volume = "29",

pages = "670--676",

journal = "Diabetic Medicine",

issn = "1464-5491",

publisher = "Wiley",

number = "5",

}

TY - JOUR

T1 - Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice

T2 - who benefits?

AU - Keen, A J A

AU - Duncan, E

AU - McKillop-Smith, A

AU - Evans, N D

AU - Gold, A E

PY - 2012/5

Y1 - 2012/5

N2 - Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P

AB - Aims To explore the effectiveness of Dose Adjustment for Normal Eating in routine clinical practice in the UK. Methods Participants were 124 adults with Type 1 diabetes who had completed a Dose Adjustment for Normal Eating course. Data were collected before the course and again 1 year later on a variety of biological, psychological and social measures. Results There were a range of significant benefits consistent with Dose Adjustment for Normal Eating aims, including: better control among those with baseline HbA(1c) = 81 mmol/mol (9.6%) (z = -2.8, P = 0.004); reduced number of participants reporting severe hypoglycaemia (¿² = 4.27, P = 0.039); total eradication of diabetic ketoacidosis (¿² = 4.17, P = 0.041) and lower diabetes-related distress (z = -4.5, P

KW - education

KW - patient education

KW - Type 1 diabetes

U2 - 10.1111/j.1464-5491.2011.03479.x

DO - 10.1111/j.1464-5491.2011.03479.x

M3 - Article

C2 - 21988559

SN - 1464-5491

VL - 29

SP - 670

EP - 676

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 5

ER -

Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this